Anticonvulsant effect of the selective 5-HT1B receptor agonist CP 94253 in mice

European Journal of Pharmacology

Volumn 541, Issue 1-2, 2006, Pages 57-63

  Wesołowska, Anna ^a   Nikiforuk, Agnieszka ^a   Chojnacka Wójcik, Ewa ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

(Mice); 5 HT1B receptor; CP 94253; Maximal electroshock; p Chlorophenylalanine; Pentylenetetrazol induced seizure; RU 24969

Indexed keywords

5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; 5 PROPOXY 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDINE; ANTICONVULSIVE AGENT; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; DIAZEPAM; FENCLONINE; FLUMAZENIL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [3 (2 DIMETHYLAMINO)ETHOXY 4 METHOXYPHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) (1,1' BIPHENYL) 4 CARBOXAMIDE; PENTETRAZOLE; PHENYTOIN; SB 216641; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1B AGONIST; SEROTONIN 1B ANTAGONIST; SEROTONIN 1D AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; ELECTRIC SHOCK; MALE; MOUSE; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; SEIZURE; STIMULATION;

ANIMALS; ANTICONVULSANTS; BENZAMIDES; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ELECTROSHOCK; FENCLONINE; INDOLES; MALE; MICE; OXADIAZOLES; PENTYLENETETRAZOLE; PIPERAZINES; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT1B; SEIZURES; SEROTONIN; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS;

EID: 33746898661     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.04.049     Document Type: Article

References (64)

1. 1B receptors in the regulation of serotonin cell firing and release in the rat brain. J. Neurochem. 79 (2001) 172-182
2. Alexander G.J., and Kopeloff L.M. p-Chlorophenylalanine-mediated decrease in susceptibility to audiogenic seizures in inbred mice. Neuropharmacology 16 (1977) 405-409
3. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
4. Bartoszyk G.D., Meyerson N., Reimann W., Satzinger G., and Von Hodenberg A. Gabapentin. In: Meldrum B.S., and Porter R.J. (Eds). New Anticonvulsant Drugs (1986), Libbey, London 147-163
5. Bell R., Donaldson C., and Gracey D. Differential effects of CGS 12066B and CP-94,253 on murine social agonistic behaviour. Pharmacol. Biochem. Behav. 52 (1995) 7-16
6. Boast C.A., Bernard P.S., Barbaz B.S., and Bergen K.M. The neuropharmacology of various diazepam antagonists. Neuropharmacology 22 (1983) 1511-1521
7. 1B receptors suppresses low but not high frequency synaptic transmission in the rat subicular cortex in vitro. Brain Res. 721 (1996) 59-65
8. Bonetti E.P., Pieri L., Cumin R., Schaffner R., Pieri M., Gamzu E.R., Müller R.K.M., and Haefely W. Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects. Psychopharmacology 78 (1982) 8-18
9. Browning R.A., Hoffman W.E., and Simonton R.L. Changes in seizure susceptibility after intracerebral treatment with 5,7-dihydroxytryptamine: role of serotonergic neurons. Ann. N.Y. Acad. Sci. 305 (1978) 437-456
10. 1B binding sites in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 347 (1993) 569-582
11. Chadha A., Sur C., Atack J., and Duty S. The 5-HT(1B) receptor agonist, CP-93129, inhibits [(3)H]-GABA release from rat globus pallidus slices and reverses akinesia following intrapallidal injection in the reserpine-treated rat. Br. J. Pharmacol. 130 (2000) 1927-1932
12. Chapman A.G., Nanan K., Williams M., and Meldrum B.S. Anticonvulsant activity of two metabotropic glutamate Group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893). Neuropharmacology 39 (2000) 1567-1574
13. 1B receptor ligands in rats: a possible mechanism of action. J. Pharm. Pharmacol. 57 (2005) 253-257
14. Dalby N.O., and Nielsen E.B. Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin. Epilepsy Res. 28 (1997) 63-72
15. 1B/D receptor antagonists. Neurosci. Lett. 188 (1995) 41-44
16. 1B/D agonist, alcohol, and aggression in mice. Psychopharmacology 157 (2001) 131-141
17. De la Torre J.C., Kawanaga H.M., and Mullan S. Seizure susceptibility after manipulation of brain serotonin. Arch. Int. Pharmacodyn. Ther. 188 (1970) 298-304
18. 1A affinity and hypotensive activity. Eur. J. Pharmacol. 112 (1985) 363-370
19. 1B binding sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 332 (1986) 1-7
20. File S.E., Pellow S., and Wilks L. The sedative effects of CL 218,872, like those of chlordiazepoxide, are reversed by benzodiazepine antagonists. Psychopharmacology 85 (1985) 295-300
21. 1B receptor agonist CP-94,253. Psychopharmacology 146 (1999) 391-399
22. 1A receptor antagonist. Behav. Brain Res. 73 (1996) 337-353
23. 1A agonist 8-OH-DPAT increases the number of spike-wave discharges in a genetic rat model of absence epilepsy. Brain Res. 807 (1998) 243-245
24. Ghauri M., Chapman A.G., and Meldrum B.S. Convulsant and anticonvulsant actions of agonists and antagonists of group III mGluRs. NeuroReport 7 (1996) 1469-1474
25. 1B receptor agonist in the rat prefrontal cortex. Pol. J. Pharmacol. 54 (2002) 625-631
26. 1B receptors causes hypothermia in the guinea pig. Eur. J. Pharmacol. 331 (1997) 169-174
27. Hoyer D., and Middlemiss D.N. Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol. Sci. 10 (1989) 130-132
28. Hoyer D., Hannon J.P., and Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 71 (2002) 533-554
29. 2C receptors as a potential therapeutic target for the design antiepileptic drugs. Curr. Top. Med. Chem. 5 (2005) 59-67
30. Iyer R.N., and Bradberry C.W. Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization. J. Pharmacol. Exp. Ther. 277 (1996) 40-47
31. 1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy. Exp. Neurol. 184 (2003) 964-972
32. B synaptic potential in rat dopamine neurons. J. Neurosci. 12 (1992) 2000-2006
33. Kłodzińska A., Bijak M., Chojnacka-Wójcik E., Kroczka B., Świa{ogonek}der M., Czuczwar S.J., and Pilc A. Roles of group II metabotropic glutamate receptors in modulation of seizure activity. Naunyn-Schmiedeberg's Arch. Pharmacol. 361 (2000) 283-288
34. 1B receptors. J. Pharmacol. Exp. Ther. 292 (2000) 1111-1117
35. 1B receptor agonist, CP-94,253. Drug Dev. Res. 26 (1992) 241-250
36. Kostowski W., Bidziński A., Hauptmann M., Malinowski J.E., Jerlicz M., and Dymecki J. Brain serotonin and epileptic seizures in mice: a pharmacological and biochemical study. Pol. J. Pharmacol. Pharm. 30 (1978) 41-47
37. 1B agonist CP-94,253. Psychopharmacology 164 (2002) 49-60
38. Liljequist S., and Engel J.A. The effects of GABA and benzodiazepine receptor antagonists on the anti-conflict actions of diazepam or ethanol. Pharmacol. Biochem. Behav. 21 (1984) 521-525
39. Litchfield J.T., and Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96 (1949) 99-113
40. 1A receptor agonists modify epileptic seizures in three experimental models in rats. Neuropharmacology 49 (2005) 367-375
41. Löscher W., and Czuczwar S.J. Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in different rodent models of epilepsy. Neurosci. Lett. 60 (1985) 201-206
42. Löscher W., and Honack D. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil. Br. J. Pharmacol. 113 (1994) 1349-1357
43. Löscher W., and Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2 (1988) 145-181
44. Löscher W., Pagliusi S.R., and Müller F. l-5-hydroxytryptophan. Correlation between anticonvulsant effect and increases in levels of 5-hydroxyindoles in plasma and brain. Neuropharmacology 23 (1984) 1041-1048
45. 1B receptor modulation of RU 24969-induced behavioral profile in rats. Pharmacol. Biochem. Behav. 71 (2002) 569-580
46. 1B auto- and heteroreceptors. Mol. Pharmacol. 58 (2000) 1271-1278
47. 1B receptors. Psychopharmacology 132 (1997) 255-260
48. Pasini A., Tortorella A., and Gale K. The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin. Brain Res. 724 (1996) 84-88
49. 1A receptors increases the seizure threshold for picrotoxin in mice. Eur. J. Pharmacol. 527 (2005) 105-110
50. Peters R.I., and Lack D.B. Audiogenic seizures and brain serotonin after l-tryptophan and p-chlorophenylalanine. Exp. Neurol. 90 (1985) 540-548
51. Prendiville S., and Gale K. Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats. Epilepsia 34 (1993) 381-384
52. 1D receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 356 (1997) 312-320
53. Przegaliński E., Baran L., and Siwanowicz J. Role of 5-hydroxytryptamine receptor subtypes in the 1-[3-(trifluoromethyl)phenyl] piperazine-induced increase in threshold for maximal electroconvulsions in mice. Epilepsia 35 (1994) 889-894
54. 1B receptor knock-out mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 361 (2000) 12-18
55. Statnick M.A., Maring-Smith M.L., Clough R.W., Wang C., Dailey J.W., Jobe P.C., and Browning R.A. Effect of 5,7-dihydroxytryptamine on audiogenic seizures in genetically epilepsy-prone rats. Life Sci. 59 (1996) 1763-1771
56. 1B receptors modulate electroshock-induced generalised seizures in rats. Br. J. Pharmacol. 144 (2005) 628-635
57. Swinyard B.A., Brown W.C., and Goodman L.S. Comparative assays of antiepileptic drugs in mice and rats. J. Pharmacol. Exp. Ther. 106 (1952) 319-330
58. 1B receptor agonist CP 94253: a possible mechanism of action. Eur. J. Pharmacol. 516 (2005) 46-50
59. 2B receptors in regulating generalised seizure threshold in rodents. Eur. J. Pharmacol. 359 (1998) 33-40
60. Wada Y., Nakamura M., Hasegawa H., and Yamaguchi N. Intra-hippocampal injection of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) inhibits partial and generalized seizures induced by kindling stimulation in cats. Neurosci. Lett. 159 (1993) 179-182
61. Wada Y., Shiraishi J., Nakamura M., and Koshino Y. Role of serotonin receptor subtypes in the development of amygdaloid kindling in rats. Brain Res. 747 (1997) 338-342
62. Watanabe K., Minabe Y., Ashby Jr. C.R., and Katsumori H. Effect of acute administration of various 5-HT receptor agonists on focal hippocampal seizures in freely moving rats. Eur. J. Pharmacol. 350 (1998) 181-188
63. 1A receptor antagonists. Eur. J. Pharmacol. 471 (2003) 27-34
64. 3H]GABA release from rat ventral tegmental area slices. J. Neurochem. 79 (2001) 914-922